Home › Grants › United States › Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Nov
Seamless Early-Stage Clinical Drug Development (Phase 1 to 2a) for Novel therapeutic Agents for the Spectrum of Alzheimer's Disease (AD) and AD-related Dementias (ADRD) (UG3/UH3 Clinical Trial Require
The purpose of this Notice of Funding Opportunity (NOFO) is to invite applications that bundle independent protocols for phase 1 clinical trials with phase 1b/phase 2a clinical trials to streamline the early-stage evaluation of promising pharmacological interventions for Alzheimer's disease (AD)...
Grant (non-repayable) Open now
- Funder
- National Institutes of Health
Funder profile and all of its programs - Amount
- Award amounts are not published in the listing; see the official page.
- Where
- United States (federal)
- Eligibility
- Open to businesses, self-employed people, nonprofits, colleges, universities, schools or research institutions and state, provincial, local or tribal governments. No cost sharing is required.
- Sectors
- Health and life sciences, Nonprofits and charities, Research and science
- Deadline
- Closes 19 November 2026
- Source
- Grants.gov XML extract (PAR-25-226)
- Last checked
- 2 November 2026
- Funder contacts
- Public organizational contacts on file Unlock full profile / Sign up
From official open data: listed in the official Grants.gov extract on 2026-11-02. The summary is from the official listing; the eligibility line is our plain-language reading of its eligibility codes. Confirm details on the official page.
Related grant lists
Health and life sciences Nonprofits and charities Research and science Governments and public bodies Schools, colleges and research institutions Nonprofits and charities United States United States (national) Federal agency November 2026
Full eligibility results and funder contacts come with Pro and Lifetime, coming soon.
Information only. GrantSift is not affiliated with any funder. A match means a program is likely eligible or worth checking, not that you will be funded. Always confirm details on the official page. Applying through official portals is free.